Should You Sell Lexicon Pharmaceuticals Inc (LXRX) Stock Monday Morning?

Lexicon Pharmaceuticals Inc (LXRX) is lower by Monday morning, with the stock declining -3.38% in pre-market trading to 1.43. LXRX's short-term technical score of 22 indicates that the stock has traded less bullishly over the last month than 78% of stocks on the market. In the Biotechnology industry, which ranks 115 out of 146 industries, Lexicon Pharmaceuticals Inc ranks higher than 31% of stocks. Lexicon Pharmaceuticals Inc has risen 37.04% over the past month, closing at $1.00 on October 9. During this period of time, the stock fell as low as $1.00 and as high as $1.50. LXRX has an average analyst recommendation of Buy. The company has an average price target of $5.55.

LXRX has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on LXRX!

See Full LXRX Report

Lexicon Pharmaceuticals Inc has a Long-Term Technical rank of 41. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 59% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, LXRX ranks better than 132% of stocks.

Important Dates for Investors in LXRX:

-Lexicon Pharmaceuticals Inc is set to release earnings on 2023-11-08. Over the last 12 months, the company has reported EPS of $-0.52. -We do not have a set dividend date for Lexicon Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Lexicon Pharmaceuticals Inc (LXRX)